Nautilus Biotechnology, Inc. (NAUT) › Shareholders' EquityNautilus Biotechnology, Inc. (NAUT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$14.51M2020: -$29.72M2021: $363.58M2022: $314.92M2023: $265.35M2024: $208.73M2025: $156.97M$156.97M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$156.97M-24.8%2024$208.73M-21.3%2023$265.35M-15.7%2022$314.92M-13.4%2021$363.58M+1323.3%2020-$29.72M-104.8%2019-$14.51M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share